MedTrace Logo

Exercise After Clinically Significant Weight Loss

NCT03685123 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 39

Last updated 2024-07-03

Study results available
· View outcomes & findings →

Summary

The Prescribed Exercise to Reduce Recidivism After Weight Loss Pilot (PREVAIL-P) study will evaluate the effect of aerobic exercise training amount on weight maintenance following clinically significant weight loss.

Conditions

Interventions

BEHAVIORAL

Physical activity recommendations

Participants in the PA-REC group will exercise at 550 MET min. per week in a supervised format

BEHAVIORAL

Weight maintenance recommendations

Participants in the WM-REC group will exercise at 970 MET min. per week in a supervised format

BEHAVIORAL

OPTIFAST weight loss

Participants will participant in an OPTIFAST medical weight loss program and exercise training

Sponsors & Collaborators

  • Pennington Biomedical Research Center

    collaborator OTHER

  • East Carolina University

    lead OTHER

Principal Investigators

  • Damon L Swift, Ph.D. · East Carolina University

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2019-02-12
Primary Completion
2020-03-15
Completion
2020-03-15

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03685123 on ClinicalTrials.gov